Trichosporonosis is an uncommon but frequently fatal mycosis in immunocompromised
patients. A multicenter retrospective study was conducted to characterize cases of proven or …

BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate the incidence and
outcome of invasive fungal infections (IFI) in patients with hematologic malignancies …

Background Imatinib slows development of chronic myeloid leukemia (CML). However,
available information on morbidity and mortality is largely based on sponsored trials …

Excess iron can be extremely toxic for the body and may cause organ damage in the
absence of iron chelation therapy. Preclinical studies on the role of free iron on bone marrow …

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

The existence of an association between infection with hepatitis C virus (HCV) and B-cell
non-Hodgkin lymphoma (B-NHL) remains controversial, largely because previous studies …

The main objective of this study was to investigate whether patients with chronic myeloid
leukemia (CML) in treatment with long-term therapy imatinib have a different health-related …

Imatinib is effective for the treatment of chronic myeloid leukemia (CML). However even
undetectable BCR‐ABL1 by Q‐RT‐PCR does not equate to eradication of the disease …

Fourteen patients with PML/RAR-positive acute promyelocytic leukemia (APL) were given
salvage therapy at the time of first molecular relapse. All patients had achieved first …

JUMP is a phase 3b expanded-access trial for patients without access to ruxolitinib outside
of a clinical study; it is the largest clinical trial to date in patients with myelofibrosis who have …